Microbial Biotechnology
Microbial biotechnology applies genetic engineering and microbial physiology to design microbes that produce valuable molecules, transform substrates, and clean up the environment.
Definition
Microbial biotechnology is the use of microorganisms, often genetically engineered, to produce useful products and to carry out processes of value in industry, medicine, agriculture, and environmental management.
Scope
This topic covers recombinant DNA technology and the production of proteins such as insulin in microbial hosts; metabolic engineering to redirect microbial metabolism toward desired products; the production of biofuels and industrial chemicals; bioremediation, in which microbes degrade pollutants; and the use of microbes in agriculture. It treats microbes as programmable factories and agents of environmental cleanup.
Core questions
- How are microbes engineered to make useful products?
- How does recombinant DNA technology enable protein production?
- How can microbes be used to degrade pollutants?
- What are the applications of microbial biotechnology across sectors?
Key concepts
- Recombinant DNA technology
- Microbial production of proteins
- Metabolic engineering
- Biofuels and industrial chemicals
- Bioremediation
Key theories
- Recombinant DNA technology
- Introducing foreign genes into microbial hosts allows them to produce proteins and metabolites not naturally part of their repertoire, the principle that launched modern biotechnology and the microbial production of human proteins.
Mechanisms
Genes encoding desired products are cloned into vectors and introduced into microbial hosts, which then express the products under controlled conditions. Metabolic engineering modifies microbial pathways to increase yield or to make new compounds. In bioremediation, the natural or engineered metabolic capabilities of microbes are used to degrade or transform pollutants in soil and water, exploiting microbial versatility for environmental benefit.
Clinical relevance
Microbial biotechnology produces recombinant pharmaceuticals such as insulin and other therapeutic proteins, industrial enzymes, biofuels, and specialty chemicals, and supports environmental cleanup through bioremediation, making it a cornerstone of the modern bioeconomy.
History
The development of recombinant DNA technology in the 1970s by researchers including Paul Berg, Herbert Boyer, and Stanley Cohen made it possible to engineer microbes to express foreign genes, leading to the first microbial production of human proteins and the birth of the biotechnology industry.
Key figures
- Herbert Boyer
- Stanley Cohen
- Paul Berg
Related topics
Seminal works
- madigan2018
- willey2020
Frequently asked questions
- How can microbes produce human proteins such as insulin?
- Using recombinant DNA technology, the gene for a human protein is inserted into a microbial host, which then synthesizes the protein as directed by the foreign gene. The microbe is grown at scale, and the protein is purified for use.